Forschungsprojekte
Ergebnisse pro Seite:
10
2018 - 2025
Effect of a combination of unpreserved trehalose and sodium hyaluron on the tear proteome in patients with dry eye disease- Prof. Dr. Dr. Franz Grus
2018 - 2023
Measurement of novel tear fluid biomarkers in increasingly prevalent retinal eye diseases: Improving diagnostic in AMD, DR/DME and glaucoma- Prof. Dr. Dr. Franz Grus
2018 - 2020
INCB 54828-201: A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner,
- PD Dr. Wolfgang Jäger
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2019
Characterization of the functional role(s) of proline-rich protein 4 (PRR4) in ameliorating dry eye disease in an in vitro hyperosmotic human corneal epithelial cell model- Dr. Natarajan Perumal,
- Prof. Dr. Dr. Franz Grus